Thorne Quercetin Phytosome
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
Safety correction: Piperlongumine is experimental. Human dose, safety, and efficacy have not been established.
Piperlongumine inhibits GSTP1 (glutathione S-transferase P1), reducing antioxidant capacity specifically in senescent cells. Senescent cells have elevated baseline ROS from persistent DNA damage signaling; further reducing antioxidant capacity tips them into ROS-triggered apoptosis. Normal cells with intact GSTP1 activity are not significantly affected.
As an Amazon Associate, Stacking Years earns from qualifying purchases.
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
8 mg fisetin per capsule
Low-dose fisetin with fenugreek galactomannans.
Best for: reviewing a low-dose fisetin label in Key Facts
View on Amazon · Affiliate link
Is black pepper the same as long pepper for piperlongumine?
No. Black pepper (Piper nigrum) contains piperine; long pepper (Piper longum) contains piperlongumine. They are different species with different bioactive alkaloids. Commercial black pepper supplements do not provide meaningful piperlongumine.
When might piperlongumine be available clinically?
No clinical trials for piperlongumine in aging are currently registered. The compound needs pharmacokinetic characterization and dose-finding studies before human senolytic use would be appropriate.
Piperlongumine has been investigated for effects on oxidative stress and cell survival in preclinical systems. Results in cultured cells—including concentrations that produce cell death—do not establish a safe oral dose, tissue exposure, or selective senolytic action in humans. A compound that affects cancer cells or senescence markers in a dish may also harm healthy tissue at an untested dose. There is no approved piperlongumine treatment for aging, and human safety and efficacy data are insufficient for a supplement protocol.
Do not purchase research-grade material or attempt to calculate a human dose from a cell-culture concentration. Products may have uncertain identity, purity, contamination, and absorption. If you are seeking treatment for cancer, infection, or another disease, use evidence-based care and discuss trial options with a qualified clinician. Laboratory mechanism comparisons with dasatinib, fisetin, or quercetin do not demonstrate that combinations are safe or beneficial.
FAQ — Is piperlongumine a proven natural senolytic? No; human clinical benefit and dosing have not been established.
Research context: Preclinical piperlongumine and senescence literature.